Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites

Journal of Medicinal Chemistry
Stefano MoroKenneth A Jacobson

Abstract

The molecular basis for recognition by human P2Y1 receptors of the novel, competitive antagonist 2'-deoxy-N6-methyladenosine 3', 5'-bisphosphate (MRS 2179) was probed using site-directed mutagenesis and molecular modeling. The potency of this antagonist was measured in mutant receptors in which key residues in the transmembrane helical domains (TMs) 3, 5, 6, and 7 were replaced by Ala or other amino acids. The capacity of MRS 2179 to block stimulation of phospholipase C promoted by 2-methylthioadenosine 5'-diphosphate (2-MeSADP) was lost in P2Y1 receptors having F226A, K280A, or Q307A mutations, indicating that these residues are critical for the binding of the antagonist molecule. Mutation of the residues His132, Thr222, and Tyr136 had an intermediate effect on the capacity of MRS 2179 to block the P2Y1 receptor. These positions therefore appear to have a modulatory role in recognition of this antagonist. F131A, H277A, T221A, R310K, or S317A mutant receptors exhibited an apparent affinity for MRS 2179 that was similar to that observed with the wild-type receptor. Thus, Phe131, Thr221, His277, and Ser317 are not essential for antagonist recognition. A computer-generated model of the human P2Y1 receptor was built and analyzed to...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Jan 5, 1981·Journal of Molecular Biology·C ChothiaD Richardson
Apr 22, 1993·Nature·G F SchertlerR Henderson
May 1, 1996·British Journal of Pharmacology·J B SchachterT K Harden
Sep 20, 1997·Nature·V M UngerG F Schertler
Feb 11, 1998·Journal of Medicinal Chemistry·E CamaioniK A Jacobson
Apr 1, 1986·Journal of Computational Chemistry·Scott J WeinerDavid A Case

❮ Previous
Next ❯

Citations

Sep 15, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Susanne HornerGünter Lambrecht
Oct 4, 2006·Journal of Computer-aided Molecular Design·Andrei A IvanovKenneth A Jacobson
Feb 13, 2007·Journal of Thrombosis and Thrombolysis·Goran K OlivecronaDavid Erlinge
Apr 13, 2011·Purinergic Signalling·Kenneth A JacobsonStefano Costanzi
Apr 13, 2011·Purinergic Signalling·Marco Cattaneo
Mar 1, 2012·Purinergic Signalling·Kenneth A JacobsonZhan-Guo Gao
Nov 11, 2003·Journal of Molecular Biology·Andreas EversGerhard Klebe
Nov 14, 2002·Biochemical Pharmacology·Yiqun Hui, Colin D Funk
Apr 12, 2003·Current Opinion in Pharmacology·Satya P KunapuliTodd M Quinton
Jun 8, 2000·Journal of Medicinal Chemistry·K A JacobsonR G Ravi
May 17, 2007·The Journal of General Physiology·David N Bowser, Baljit S Khakh
Jul 6, 2004·European Journal of Biochemistry·Ke-He RuanCheng-Huai Ruan
Jan 8, 2009·Cephalalgia : an International Journal of Headache·M ReitzJ Ellrich
Dec 24, 2004·Molecular Interventions·Kenneth A JacobsonZhan-Guo Gao
Jun 2, 2000·Biochemical and Biophysical Research Communications·K SakJ Järv
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·E A MellorJ A Boyce
May 27, 2004·Proteins·Paul R GouldsonChristopher A Reynolds
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·M Cattaneo
May 14, 2004·Journal of Thrombosis and Haemostasis : JTH·T M QuintonS P Kunapuli
Mar 31, 2015·Nature·Dandan ZhangBeili Wu
Nov 1, 2005·Pharmacology & Therapeutics·Ivar von Kügelgen
Jul 28, 2016·Angewandte Chemie·Shuguang YuanKrzysztof Palczewski
Oct 13, 2004·Biochemical Pharmacology·Carsten HoffmannKenneth A Jacobson
May 2, 2017·Brain : a Journal of Neurology·Matilda DegnMehdi Tafti
Nov 23, 2016·ChemMedChem·Kerstin BurkertAnnette G Beck-Sickinger
Jan 17, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Zubair A KarimFadi T Khasawneh
Mar 12, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Jane E NormanAndrew D Mumford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.